- Connect with LRI:
- YouTube
- Change.org
Submitted by beth on Thu, 06/10/2010 - 13:20.
Human Genome seeks FDA nod to market lupus drug
Says files Biologics License Application with FDA
Thursday, June 10, 2010
Human Genome Sciences Inc said it has sought for U.S. regulatory approval to market its experimental lupus drug Benlysta that the biopharmaceutical company is co-developing with partner GlaxoSmithKline Plc.
